Statin Intolerance
source

Statin Intolerance

(24)
Price
Free
Category
Health & Fitness
Last update
May 05, 2021
Publisher
American College of Cardiology Foundation Contact publisher
Loading...

Ratings & Reviews performance

Ratings & Reviews performance provides an overview of what users think of your app. Here are the key metrics to help you identify how your app is rated by users and how successful is your review management strategy.

Number of reviews,
total
24
Avg rating,
total
⭐4.5
Loading...

Description

1404 chars

ACC’s Statin Intolerance App helps clinicians care for patients reporting muscle symptoms while on a statin. • Answer questions to evaluate possible intolerance to a patient’s current statin prescription. • Follow steps to treat and manage a patient who reports muscle symptoms on a statin. • Compare statin characteristics and drug interactions to determine the best cholesterol-lowering therapy for the patient. The recommendations in this app are meant to support clinical decision making. They are not meant to represent the only or best course of care, or replace clinical judgment. Therapeutic options should be determined jointly after a clinical evaluation and discussion between the patient and their care provider. The app should not be used by patients to guide their own care. The information and recommendations in this app are derived from ACC/AHA’s 2013 Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults. It was developed as part of the American College of Cardiology’s “LDL: Address the Risk” Initiative and further refined and vetted by physicians, physician assistants, nurse practitioners, pharmacists, and other relevant specialties; and through user testing in care settings with patients. Financial support for the app was generously provided by Amgen. All content was developed independently with no sponsor involvement.

Screenshots

https://play-lh.googleusercontent.com/tDTo6lA6Eo897dVzMJ32X4CxoG8w8DU93uaXPGY3M4uGXHtXsGvUNnV8ncPWyeKScHI=w720-h310https://play-lh.googleusercontent.com/T5oQ-znRkm_Ya9MmBAl3vZyLH_-IUtSeP_UnCcbZUnXfURIIcqAh8bHFZht-8a_yHw=w720-h310https://play-lh.googleusercontent.com/6g44M-3Tj5Yac8phCeil4grKiL7uNUCwtFhZHxBjluXnrNKNIrCkaQilgIWiwGRZrNI=w720-h310https://play-lh.googleusercontent.com/7Ra07trm-70odPQuCUoTovl0W-G1QZqGoLrZoVSJAGLN2U7C9s3NEime8CkJ7CxgWp8v=w720-h310https://play-lh.googleusercontent.com/SAsbeHvRC_tQ0G8qKqMGhkcOiA_7yFXFeOEM9r3D5L2mLIK6aPPr7JiH-iWj6cg8LP4=w720-h310https://play-lh.googleusercontent.com/_dhWKcvwY_LT4eHSL-E2kHTLtgf97bsIPChJPpHbcWZBhAMZtk1Sd79RmpHKPhRLSF8=w720-h310https://play-lh.googleusercontent.com/9nYRT4-GgFEMcrNlMi5r2IFKpEsQUzmNzWQIb7G2gEwXEPEZ7kVs-tIzO9nREPFBx7w=w720-h310https://play-lh.googleusercontent.com/zbA3hhwPmVgg4YLxUsKLFBRmRkUbT06MkAAelzk3S6yX0O-g_tIpyGtzpthC2vshrjE=w720-h310https://play-lh.googleusercontent.com/c9uFFgZFiJTyyfSQaRTWSVdEn_ffrbpnLcry7oHkbEkgmALTlTJuWO8SVVB9Nt5yGw=w720-h310https://play-lh.googleusercontent.com/7-1OCPvHu5JbgZEzDgsX7LiYscMJCZgtkdVfbbo9Hxy173hbG3WId5jQZZOiQNB8kQ=w720-h310https://play-lh.googleusercontent.com/350fPf0AymtYSKdmZAV4qTRFrQW4JOUeNvfOrFHauOrLZBJYyM5aPjVcf9cXSErqw_c=w720-h310https://play-lh.googleusercontent.com/kjJ6taV8oM4SxXdI8XJxe-9ewBv4BN-szvhLUDUhpFTmFEUPx53L26tk2XnMwI_TOIgt=w720-h310https://play-lh.googleusercontent.com/FscoJ0TsulgQivuFceVHu9bTFZIPzeSHBQFTeYrNi20StsI6T8o6kYfDR6Kdr5dIUkA=w720-h310https://play-lh.googleusercontent.com/jG0cERYIup60I1_59hV4xIkrC3wFNVyrA4ZlqcBSJ16_BS5VuE5YjklctgARQ5gKY5w=w720-h310https://play-lh.googleusercontent.com/w83kmiGSjF1qxjtmCTjwl0FjPIZNNvxWu9HbhF8wR1aEmul2LSOt6D7yELYUFVILDuc=w720-h310https://play-lh.googleusercontent.com/-tzIFmvBScqGmiIbSH14pKzqSLb6FUDGTS0A8CdpHqCUcyoElzuQlQoYPS4A3r_waQ=w720-h310https://play-lh.googleusercontent.com/iqVVy8_dKNxsVggWLjmxaQigbnHi_VYdIXISRbyqUMNfyy4K_s7azPy2b3TW7wnDhgM=w720-h310https://play-lh.googleusercontent.com/TOl7TWMGnssq8Fb1TaA5axm3KBWwCLMino1-72fXqLgGL6F_Fx-pL2Kit4_QQdrqrg=w720-h310https://play-lh.googleusercontent.com/wLEjZkBHKvgFa9elp3oFEO-UpS0g9WpcsgXIyIIHqzFwnyoAWOj3N93VXU6LXMqJAQ=w720-h310https://play-lh.googleusercontent.com/iry6fVRfBkm9xNDBHSTR6zOp-BM_HhMwqc98P2de9dLNBr3YFrPA13vq8g97WHdk-w=w720-h310https://play-lh.googleusercontent.com/kD02_BWi4ZhDiUFsDy-bIZQC9XLIgYjz_eqgP5ecRP3RHY_llQRf8wisvEZmTC82vP8=w720-h310https://play-lh.googleusercontent.com/X5r7mrDW0MATAOUcLmAuM5FtQtj2Wrwpz3HtZ52foEwond_glMSi-NdaPmg3xORw_zw=w720-h310https://play-lh.googleusercontent.com/1iIDV6KIwkBgg13XhjxLOFyp8FHI-cgIO_d9doF-JBvosVeSm4armCGp8dh9tmf7fA=w720-h310https://play-lh.googleusercontent.com/2Xp9sF5I1bmS2yUpOOA60s4mSygAncSdWmXYW8LkloIT_0CI8_b35SRT5r617M2oBIyi=w720-h310
Loading...
Loading...

Find growth insights on our blog

React to user feedback and market trends faster